SEC Form 10-K filed by Gilead Sciences Inc.
$GILD
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $125.00 | Overweight | Cantor Fitzgerald |
| 3/4/2025 | $115.00 → $132.00 | Outperform | Oppenheimer |
| 2/18/2025 | $120.00 | Hold → Buy | Deutsche Bank |
| 2/13/2025 | $108.00 | Hold → Buy | DZ Bank |
| 1/10/2025 | $87.00 → $113.00 | Equal-Weight → Overweight | Morgan Stanley |
| 12/10/2024 | $109.00 | Buy | BofA Securities |
| 11/15/2024 | $110.00 | Outperform | Wolfe Research |
| 11/14/2024 | $125.00 | Buy | Citigroup |
4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)
4 - GILEAD SCIENCES, INC. (0000882095) (Reporting)